By now, you have probably heard of GLP-1 agonists, like the popular semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). With the epidemic of overweight and obesity in our country, I cannot ignore the compelling data on GLP-1 agonists and weight loss. That being said, I have one concern that stands out when considering this class of medication - read my blog to learn more.

CoQ10 is a nutrient that supports mitochondrial function for cellular energy production and also acts as an antioxidant. It can be synthesized in the body, but its production declines with age.

Other reasons that CoQ10 levels can decline in the body include an increased demand in certain tissues, other nutritional deficiencies, or the use of statin medications (common medications for cholesterol levels).